Navigation Links
Zimmer Holdings to Present at Upcoming Investor Conferences
Date:9/1/2009

WARSAW, Ind., Sept. 1 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH) announced today it will be participating in the following investor conferences during the month of September:

  • Thomas Weisel Partners Healthcare Conference 2009 in Boston, Mass., on September 9, 2009, at 11:30 a.m. Eastern Time;
  • Morgan Stanley Healthcare Unplugged 2009 Conference in New York, N.Y., on September 14, 2009, at 8:35 a.m. Eastern Time; and
  • UBS Global Life Sciences Conference in New York, N.Y., on September 21, 2009, at 8:00 a.m. Eastern Time.

Live webcasts of the presentations can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com. The webcasts will be archived for replay following the conferences.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit www.zimmer.com


'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Zimmerman Travels Across Country for $10M Weight Loss
2. Zimmer Holdings to Present at BMO Capital Markets Ninth Annual Focus on Healthcare Conference
3. Zimmer Holdings, Inc. Reports Second Quarter 2009 Financial Results
4. Zimmer Holdings to Present at Deutsche Bank 34th Annual Health Care Conference
5. Zimmer Holdings, Inc. Reports First Quarter 2009 Financial Results
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2009 Results
7. Zimmer Announces Expiration of Deferred Prosecution Agreement
8. Zimmer Holdings Names Marc Casper to Board of Directors
9. Nyer Medical Appoints Sandra Zimmerman as Chief Financial Officer
10. Zimmer Presents Trabecular Metal Technology Experience at AAOS Annual Meeting
11. Zimmer Reports Fourth Quarter and 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... ... May 26, 2016- In search of the K. Warriors, Shaolin Institute is ... Warriors” on June 4, 2016 at Ashbury Hotel and Suites 600 West Interstate 65 ... by Shaolin Institute and sanctioned by KSF (Kungfu Sanda Federation), This is the 28th ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon ... to Women and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel ... year, Geri Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program at ...
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... in scholarships to students studying complementary medicine. Allison Outerbridge is this year’s ... her award on May 18 at the university’s Student Leadership Awards ceremony. , ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... thousands of defective respirators, according to court documents and SEC filings. A ... and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 Kitov ... focused on late-stage drug development, today announced the ... of pivotal batches required for registration of KIT-302 ... This follows Kitov,s announcement in December ... met its primary efficacy endpoint. "We ...
(Date:5/26/2016)... A key trend that will ... of new treatments. Cardax, a development stage life sciences ... therapy is expected to fulfil large unmet medical needs ... studies to develop new treatments for osteoarthritis. One such ... in osteoarthritis are being investigated, and early trials of ...
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
Breaking Medicine Technology: